These observations led us to perform a recent study analyzing the abundance of CHRM1 protein in a large cohort of postmortem human brain tissues, specifically temporal cortices, derived from AD (N = 74) and clinicopathologically normal individuals (N = 19) (Sabbir et al., 2022). This evidence concerns the gene CHRM1 and Alzheimer disease.